Results 21 to 30 of about 13,238 (197)

Best Achievements in Clinical Medicine in Diabetes and Dyslipidemia in 2020 [PDF]

Endocrinology and Metabolism, 2021
Over the last two decades, our understanding of diabetes and treatment strategies have evolved tremendously, from scientific, mechanistic, and human perspectives.
Eun-Jung Rhee, Mee-Kyung Kim, Won-Young Lee   +2 more
doaj   +1 more source

Genetics of Dyslipidemia

Arquivos Brasileiros de Cardiologia, 2016
Lipoproteins constitute a set of proteins and lipids, organized to facilitate the transport of lipids through blood plasma. Elevated or decreased levels of these lipoproteins may be related to genetic alterations in 40% to 60% of cases.1 This fact explains why it is common to find lipid abnormalities in several members of the same family.
García-Giustiniani, Diego, Stein, Ricardo   +1 more
openaire   +4 more sources

PCSK9 gene participates in the development of primary dyslipidemias

, 2021
Dyslipidemias are a group of diseases, which are characterized by abnormal blood concentrations of cholesterol, triglycerides and/or low-density lipoprotein-cholesterol (LDL-c).
Alpuche Osorno JJ, Pérez-Santiago AD, Matías-Pérez D, Sánchez Medina MA, García-Montalvo IA   +4 more
core   +1 more source

Lipid profile of Mexican children with Down syndrome

BMC Pediatrics, 2021
Introduction Down syndrome (DS) is associated with various congenital anomalies and metabolic alterations, such as dyslipidemias, that can lead to cardiovascular disease in adulthood.
Silvestre Garcia-de la Puente, Karla A. Flores-Arizmendi, María J. Delgado-Montemayor, Tania T. Vargas-Robledo   +3 more
doaj   +1 more source

Dyslipidemias associated with endocrine disorders: a position statement of the working group of the nutrition hormones and metabolism club of the italian society of endocrinology (SIE). [PDF]

J Endocrinol Invest
Purpose: Dyslipidemias are highly prevalent metabolic disturbances and represent a major driver of atherosclerotic cardiovascular disease. Beyond primary forms, numerous endocrine diseases induce secondary dyslipidemias that substantially modify lipid ...
Muscogiuri G, Albertelli M, Arnaldi G, Barrea L, Bellastella G, Bonomi M, Caputo M, Caprio M, Cignarelli A, Di Gioia L, Frasca F, Ferrari D, Gambineri A, Gasco V, Gatto F, Giandalia A, Giordano R, Infante M, Isidori A, Malandrino P, Occhi G, Pivonello R, Prencipe N, Prodam F, Simeoli C, Verde L, Vignozzi L, Cannavò S, Giorgino F, Colao A, Aimaretti G, Ferone D, Perrini S.   +32 more
europepmc   +2 more sources

Treatment of dyslipidemia [PDF]

F1000Prime Reports, 2014
Atherosclerotic cardiovascular disease (including coronary heart disease, stroke and peripheral arterial disease) is the leading cause of death globally. Abnormal blood lipids (dyslipidemia), smoking, and high blood pressure are responsible for more than 75% of cases.
Tonkin, Andrew, Byrnes, Allison
openaire   +2 more sources

Dyslipidemias - modern understanding and management [PDF]

, 2015
Сърдечно-съдовите заболявания (ССЗ) са основна причина за смърт и инвалидност у нас и по света. За развитието им основно значение има нарушението в липидния метаболизъм, което води до атеросклероза на съдовете.
Yotov, Yoto; First Cardiology Clinic, St. Marina University Hospital, Varna, Sector of Cardiology and Rheumatology, Department of Internal Diseases, Medical University of Varna
core   +1 more source

Atherogenic dyslipidemia

Indian Journal of Endocrinology and Metabolism, 2013
Atherogenic dyslipidemia (AD) refers to elevated levels of triglycerides (TG) and small-dense low-density lipoprotein and low levels of high-density lipoprotein cholesterol (HDL-C). In addition, elevated levels of large TG rich very low-density lipoproteins, apolipoprotein B and oxidised low-density lipoprotein (LDL), and reduced ...
C N Manjunath, Jayesh R Rawal, Paurus Mehelli Irani, K Madhu   +3 more
openaire   +3 more sources

Plant Sterols and Stanols for Pediatric Patients with Increased Cardiovascular Risk

Children
The atherosclerotic process begins in childhood and progresses throughout adult age. Hypercholesterolemia, especially familial hypercholesterolemia (FH) and metabolic dysfunctions linked to weight excess and obesity, are the main atherosclerosis risk ...
Cristina Pederiva, Giacomo Biasucci, Giuseppe Banderali, Maria Elena Capra   +3 more
doaj   +1 more source

Evaluation of Lipid Profiles of Children and Youth from Basic Health Units in Campinas, SP, Brazil: A Cross-Sectional Laboratory Study [PDF]

Arquivos Brasileiros de Cardiologia
Background: Among dyslipidemias, hypercholesterolemia is considered the main risk factor for cardiovascular diseases in adults. In childhood and adolescence, elevated total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) are positively ...
Érica Ivana Lázaro Gomes, Vanessa Helena de Souza Zago, Eliana Cotta de Faria   +2 more
doaj   +3 more sources